See also this year's filing and all EDGAR filings for this company.
PDF Report 0001621443_2017_Zynerba_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001621443, Zynerba Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 36,410,692 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 143,382 |
| 3 | remainder_Assets | 200 |
| 4 | LiabilitiesCurrent | 6,966,966 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,430,252 |
| 9 | ResearchAndDevelopmentExpense | 16,784,626 |
| 10 | remainder_Expenses | -27,543 |
| 11 | remainder_Revenues | 7,250 |
| 12 | remainder_NetIncome | -208,422 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 36,554,274 |
| 1 | Liabilities | 6,966,966 |
| 2 | Expenses | 23,187,335 |
| 3 | Revenues | 7,250 |
| 4 | StockholdersEquity | 29,587,308 |
| 5 | NetIncome | -23,388,507 |
| 6 | ComprehensiveNetIncome | -23,388,507 |
| 7 | BaseVar | 33,462,124 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.89 |
| 9 | EconomicCapitalRatio | 2.95 |